Novartis Bioventures Ltd, 10% Owner at Galera Therapeutics, Inc. (GRTX), sold 35,622 shares at $9.66 ($342K) on 2020-06-05, disclosed to the SEC on 2020-06-09.
Open-market sale of $342k GRTX by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $9.66 | 8,652 | $84K | 24.4% |
| 2 | $9.66 | 8,652 | $84K | 24.4% |
| 3 | $9.66 | 5,659 | $55K | 16.0% |
| 4 | $9.66 | 5,659 | $55K | 16.0% |
| 5 | $9.38 | 7,000 | $66K | 19.2% |
| Total | $9.60 avg | 35,622 |
| $342K |
| 100% |
| Filing → |
| BCYC | BUY | 2019-05-30 | $2.4M | — | Filing → |
| ARPO | SELL | 2019-04-15 | $185K | — | Filing → |
| ARPO | SELL | 2019-04-10 | $367K | — | Filing → |